Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Development Strategy for Early-Stage Assets: The Commercial-Clinical Handshake, Upcoming Webinar Hosted by Xtalks | ||
| By: PR Newswire Association LLC. - 26 Feb 2024 | Back to overview list |
|
|
In this webinar, learn why product development strategy should start with the end in mind. The featured speaker will discuss the importance of incorporating patient, healthcare practitioner and payer needs early in the development process. Attendees will learn why target product profile development is a multi-disciplinary team sport. TORONTO, Feb. 26, 2024 /PRNewswire-PRWeb/ -- Product development from translation to registration has become increasingly more difficult and costly. Ambitions are high but success rates are low. If development is a tough path, commercialization is even harder. In 2022, the average year-one sales per branded product were a mere $65M. In 2021, 45 percent of all prescriptions were rejected or blocked. To realize an asset's full potential and differentiate it from the competition, it takes a strategy built with a multi-disciplinary approach that recognizes the needs of patients, healthcare practitioners and payers early in the development process. To realize an asset's full potential and differentiate it from the competition, it takes a strategy built with a multi-disciplinary approach that recognizes the needs of patients, healthcare practitioners and payers early in the development process. This webinar will discuss the importance of incorporating the commercial voice early in the development process. It will focus on the need to create a handshake between commercial and clinical on the key attributes of an asset, the importance of developing a meaningful target product profile and the evolving nature of the commercial landscape. Register for this webinar today to gain insights into the importance of developing a meaningful target product profile and incorporating the commercial voice early in development. Join William Bainbridge, Senior Director, Commercial Strategy, Premier Consulting, for the live webinar on Tuesday, March 19, 2024, at 11am EDT (4pm CET/EU-Central). For more information, or to register for this event, visit Development Strategy for Early-Stage Assets: The Commercial-Clinical Handshake. ABOUT XTALKS Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers. To learn more about Xtalks visit https://xtalks.com Media Contact Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, https://www.xtalks.com
SOURCE Xtalks 
|
||
|
||
 | Back to overview list | |
View original content to download multimedia: